Do Endotypes Predict Response and Sequelae in OSA Patients
Phase 2
200
about 6.4 years
21–65
1 site in CA
What this study is about
This trial is testing whether different underlying causes of Obstructive Sleep Apnea (OSA) predict how well people respond to treatment and what problems the disease might cause. The goal is to understand if knowing these 'endotypes' can help doctors choose the best way to treat each individual with OSA.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Supplemental Oxygen
- 2.Take Eszopiclone
- 3.Use Continuous Positive Airway Pressure (CPAP)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
eszopiclone, VARIOUS
oral (Oral Tablet)
Secondary: Brief Pain Inventory (Short Form), Diastolic Blood Pressure, Epworth Sleepiness Scale (ESS), Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT-F), Insomnia Severity Index (ISI), PROMIS (Patient-Reported Outcomes Measurement Information System) pain intensity, PROMIS (Patient-Reported Outcomes Measurement Information System) pain interference, Pittsburgh Sleep Quality Index (PSQI)
therapeutic